The earliest successes of anti-CD6 Abs in autoimmune diseases [1–3] were obtained in the treatment of rheumatoid arthritis (RA), psoriasis, and multiple sclerosis (MS) (Table 1). The gene discussed is CD6; the disease is myeloid sarcoma.